ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

Clinical Significance Of Sickle Cell Disease As a Major Hemoglobinopathy

Updated on January 20, 2014

A Sickle Cell Patient

Source

Introduction

This is the most widespread hemoglobinopathy. In Africa, its epidemiology is unique and very popular, cutting across the sahara regions (especially west African regions) and affecting more than 30% of the populace of these Nations. Hemoglobin S offers partial protection against falciparum malaria (balanced polymorphisms). The genetic variants are:

The genetic variants Of Hemoglobin

 
 
Sickle cell anemia
Homozygous S-S
Sickle cell trait
Heterozygous A-S
Hemoglobin S-thalasemia
Heterozygosity between sickle cell hemoglobin and thalasemia
Hemoglobin S-C disease
Heterozygosity between S and C

The Sickled Shaped Blood Cells

Source

Pathology

Hemoglobin S is formed by the substitution of valine in place of glutamic acid in the sixth residue of the beta chain of adult hemoglobin. Hemoglobin S is soluble in the oxygenated state and the red cells containing it maintain normal shape and function. Under conditions of lowered oxygen tension, it forms liquid crystals (tactoids) which distort the erythrocytes to assume the characteristic sickle shape. Such cells are rigid and they obstruct the microcirculation. This results in sludging and occlusion of the microcirculation which manifests as dysfunction of many organs. Generally, symptoms occur if the number of sickle cells exceeds 50% of the total. In Hb S-C disease and Hb S-D disease, the clinical severity is more. In Hb S-thalassemia, the presence of large amounts of Hb F protects against sickling. Sickled cells are easily destroyed and this leads to hemolytic anemia. Maximal lesions are seen in the heart, lungs, spleen, bone marrow, brain and placenta. Factors which precipitate sickling are hypoxia, acidosis, dehydration, fever and infections. Occlusion of the microcirculation resulting from sickling aggravates acidosis further, thereby establishing a vicious circle. Most of the clinical features can be explained on the basis of anemia, hemolysis, obstruction to microcirculation and siderosis of parenchymal organs.

Diagnosing Sickle Cell Disease

Source

Diagnosis, Prognosis And Prophylaxis

Diagnosis

In endemic areas, the clinical diagnosis can be easily confirmed by demonstrating the sickling phenomenon. One drop of blood is mixed with an equal volume of 2% sodium metabisulphite solution. A cover slip is applied and the edges are sealed with Vaseline after incubation at 370 for 30 minutes. Sickle cells are demonstrable. Sickling may occur with other hemoglobins also in some cases. Electrophoresis of Hb at pH 8.6 shows Hb S as a slow-moving band.

Course and prognosis

Majority of severe cases die in childhood before reaching five years of age. Only one-fourth live up to 30 years or more. Acute splenic sequestration, septicemia, meningitis and gastroenteritis account for most of the deaths. Pregnancy carries increased risk to mother and fetus.

Prophylaxis

These include;

  1. Screening of babies born to carriers of Hb S, with a view to make an early diagnosis and prevent crisis,
  2. Detection of an affected fetus by amniocentesis and termination of the pregnancy, and
  3. Genetic counseling to avoid marriage between heterozygotes.

A recessive Inheritance

Source

Clinical Manifestation

Sickle cell disease may present in different ways. Symptoms occur after the sixth month of age since the full complement of beta chains is not produced in the first few months of life. When the disease is severe, growth is retarded with delay in skeletal maturation giving rise to the characteristic picture of stunted growth, long limbs, narrow hips and exaggerated lordosis. Sickle cell crisis supervene frequently involving several organs, and untreated cases are fatal before the third decade. This extreme form is more common in Africans. In mild cases, there may be only mild anemia, growth and development being normal. This variety is more common in the Middle East. In India, the cases show an intermediate severity.

Early symptoms include anemia, hepatosplenomegaly, retardation of growth, recurrent infections and painful swellings of the hands. Crises are characterized by painful episodes associated with constitutional disturbances like fever, worsening of anemi andsymptoms referable to organ systems. Cardiomegaly, cardiac murmurs, pulmonary hypertension and cor pulmonale are late manifestations. Tender hepatomegaly may result from infarction of the liver. Infection may convert these infarcts into abscesses. Cholelithiasis and leg ulcers may develop.

The splenic sequestration syndrome is characterized by sudden painful splenomegaly associated with rapid fall in hemoglobin and hypotension. This is seen more frequently in children. The condition may be fatal if left untreated. As a result of repeated infarction, the spleen may shrink and be converted into a fibrous streak. This is referred to as autosplenectomy. The infarcts may become calcified. The spleen becomes impalpable in sickle cell anemia by the age of 10-12 years. In other sickle cell syndromes such as S-thalassemia, S-C and S-D, the spleen remains palpable throughout life.

Renal involvement manifests as hematuria, hyposthernuria, acute nephritis or occasionally nephritic syndrome. Priapism may occur due to obstruction to corpora cavernosa. Skeletal symptoms are common. These include bone pain, arthralgia, backache, dactilitis, salmonella osteomyelitis and multiple bone infarcts. Dactilitis is seen in young children. The femoral and humeral heads may undergo avascular necrosis. Neurovascular accidents develop due to occlusion of intracranial vessels. Blindness may develop due to repeated vitreous hemorrhages and retinal tears and detachment. Aplastic crises occur rarely and are characterized by the rapid development of severe anemia due to marrow hypoplasia and accelerated hemolysis.

Managing Sickle Cell Anemia

Source

Management

Aim of treatment is to prevent deterioration and avoid crises. The hemoglobin level should be maintained around 8 g/dl with the hematocrit around 25%. Since folic acid deficiency may develop in a few cases, supplementation of 1mg folic acid dailu is beneficial. Intercurrent infections should be treated promptly. Crisis have to be managed as emergencies with rest, sedation, maintenance of fluid and electrolyte and blood transfusions.

Transfuson or partial exchange transfusion may be needed during hemolytic or sickling crises. Several drugs such as nitrates, phenothiazines, corticosteroids, dextran, hyperbaric oxygen, anticoagulants and urea have been used for treating sickling crises with variable results. Intravenous injection of 2.0ml of 40% magnesium sulphate relieves pain.

Potassium cyanate has been tried with a view to increase the oxygen affinity of Hb S by carmanylation. This drug helps in increasing the lifespan of erythrocytes but its neurotoxicity limits its prolonged use. Bone marrow transplantation has been tried experimentally in a few cases with encouraging results.

© 2014 Funom Theophilus Makama

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: "https://hubpages.com/privacy-policy#gdpr"

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)